These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16640173)

  • 41. Assessment and management of hypertension in patients with type 2 diabetes.
    Thomas MC; Atkins R
    Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].
    van den Meiracker AH; van Montfrans GA
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):886-8. PubMed ID: 16686086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ASCOT a four horse race.
    Sever P
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):51-4. PubMed ID: 16470483
    [No Abstract]   [Full Text] [Related]  

  • 48. Will ASCOT change the form of anti-hypertensive therapy?
    Bilous R
    Diabet Med; 2006 Jan; 23(1):13-4. PubMed ID: 16409559
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment strategies in essential arterial hypertension].
    Waeber B
    Rev Prat; 1999 Mar; 49(5):520-5. PubMed ID: 10358402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The burden of blood pressure: where are we and where should we go?
    Hamet P
    Can J Cardiol; 2000 Dec; 16(12):1483-7. PubMed ID: 11137913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM; Segura J
    Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertension and lipids.
    Sznajderman M
    Blood Press Suppl; 1996; 1():14-7. PubMed ID: 9162431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Women and hypertension].
    Mitchell A; Philipp T
    Herz; 2005 Aug; 30(5):401-4. PubMed ID: 16132242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antihypertensive therapy: who should be treated and to which target?].
    Waeber B; Burnier M
    Rev Med Suisse; 2006 Jan; 2(48):123-4, 126-7. PubMed ID: 16463797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular consequences of hypertension: therapeutic effects on organ damage and on cardiovascular events.
    Zanchetti A
    Blood Press Suppl; 1994; 1():1-4. PubMed ID: 8205291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypertension. New French recommendations].
    Milon H; Mestre C; Lantelme P
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1479-86. PubMed ID: 11190299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials.
    Verdecchia P; Gentile G; Angeli F; Mazzotta G; Mancia G; Reboldi G
    J Hypertens; 2010 Jul; 28(7):1356-65. PubMed ID: 20375907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taking risks: primary prevention of cardiovascular events.
    Vallance P
    N Z Med J; 2001 May; 114(1132):223-4. PubMed ID: 11453356
    [No Abstract]   [Full Text] [Related]  

  • 59. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.
    ; ; ; ; ;
    Heart; 2005 Dec; 91 Suppl 5(Suppl 5):v1-52. PubMed ID: 16365341
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipid lowering: another method of reducing blood pressure?
    Wierzbicki AS
    J Hum Hypertens; 2002 Nov; 16(11):753-60. PubMed ID: 12444536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.